Nektar Therapeutics reported $21.44M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Amgen AMGN:US $ 1.33B 99M
Astrazeneca AZN:US 3.27B 209M
Baxter International BAX:US $ 817M 27M
Biocryst Pharmaceuticals BCRX:US $ 38.02M 3.74M
Biogen BIIB:US $ 572.6M 62.3M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Dr.Reddys Laboratories DRRD:IN 23.8B 38M
Eisai 4523:JP 92.31B 18.18B
Eli Lilly And LLY:US $ 1.63B 67.2M
Esperion Therapeutics ESPR:US $ 29.61M 772K
Exelixis EXEL:US $ 122.76M 19.9M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 195.5B 18.5B
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Immunogen IMGN:US $ 23.79M 7.14M
Ironwood Pharmaceuticals IRWD:US $ 30.12M 1.26M
Karyopharm Therapeutics KPTI:US $ 37.34M 1.43M
Macrogenics MGNX:US $ 13.67M 2.58M
Merk MRK:US $ 2.42B 118M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Seattle Genetics SGEN:US $ 220.26M 46.03M
Takeda 4502:JP 231.48B 8.05B
Teva Pharmaceutical TEVA:IT 849M 30M
Xencor XNCR:US $ 11.09M 182K
YTE INCY:US $ 253.28M 43.69M